Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Use the filters or search function to help find relevant consultations.
Search
52 result(s) found, displaying 26 to 50
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationView the outcomes of public consultation on building a more robust medicine supply
-
ConsultationThe IMDRF working group is seeking comments from interested parties on the proposed guidance document. Closing date: 19 April 2021
-
ConsultationTGA is seeking comments on whether the Australian medical device regulatory framework should be aligned to the EU framework for medical devices containing nanomaterials. Closing date: 9 April 2021
-
ConsultationTGA is consulting on a proposed standard for vaporiser nicotine products (e.g. nicotine e-liquids). Closing date: 31 March 2021
-
ConsultationThe closing date has been extended until 30 March 2021.
-
ConsultationThis consultation is to obtain feedback in relation to proposals to provide clarity on residual claims for disinfectants. Closing date: 26 March 2021
-
ConsultationThe TGA is seeking comments on the proposed fees and charges for the 2021-22 financial year. Closing date: 17 March 2021
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 4-5 November 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationTGA is seeking feedback on a proposal to streamline how information about certain therapeutic goods formulations is entered into TGA electronic systems when seeking market approval. Closing date: 24 February 2021
-
ConsultationA submission summary on the Australian Regulations definition of CCS consultation is available on our consultation hub
-
ConsultationA further update by the TGA on the proposed reforms to medicinal cannabis, labelling and packaging requirements.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 27 January 2020
-
ConsultationClosing date extended to 14 December 2018
-
ConsultationAdvisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'. Closing date 31 October 2018
-
ConsultationThe IMDRF sought comments on a proposed guidance document and two information documents
-
ConsultationThe IMDRF sought comments on a proposed document and its annexes
-
ConsultationInvitation to comment on proposed Poisons Standard amendments. Closing date: 28 September 2018
-
ConsultationThe IMDRF is seeking comments on a proposed guidance document
-
ConsultationThe TGA is seeking comments on the proposed guidance for the use of Boxed Warnings for prescription medicines. Closing date: 31 August 2018
-
ConsultationThe TGA sought comments on the proposed Schedule 3 substances to be added to Appendix H of the Poisons Standard to allow them to be advertised direct to consumers. Closing date 9 July 2018
-
ConsultationCarbendazim has been deferred from the June 2018 ACCS meeting at the applicant’s request.
-
ConsultationConsultation on options for a regulatory response to the potential misuse of prescribed Schedule 8 opioids in Australia